[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"biomarker:serine-threonine-protein-kinase-mtor":3},{"name":4,"total":5,"recruiting":6,"trials":7},"Serine\u002FThreonine-Protein Kinase mTOR",3,2,[8,16,23],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT05933395","Genetically-informed Therapy for ER+ Breast Cancer Post-CDK4\u002F6 Inhibitor",[12],"Phase 2","RECRUITING","2026-08-26T02:15:24.145250Z","2026-05-05T02:43:29.132138Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":21,"content_modified":22},"NCT05949658","Rapalog Pharmacology (RAP PAC) Study",[20],"Phase 1","2026-08-26T02:18:21.216897Z","2026-07-05T05:32:16.738553Z",{"nct_id":24,"title":25,"phases":26,"status":28,"updated_at":29,"content_modified":30},"NCT07218575","Double-Blind Trial of Everolimus for Improving Social Abilities in PTEN Germline Mutations",[27],"Phase 2\u002FPhase 3","NOT_YET_RECRUITING","2026-08-26T02:19:16.454910Z","2026-06-05T00:55:50.372501Z"]